{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:48:25Z","timestamp":1791186505868,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.taap.2012.04.012","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T03:59:12Z","timestamp":1334721552000},"page":"292-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["New therapeutic aspect for carvedilol: Antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage"],"prefix":"10.1016","volume":"261","author":[{"given":"Nadia M.","family":"Hamdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebtehal","family":"El-Demerdash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2012.04.012_bb0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"Catalase in vitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.taap.2012.04.012_bb0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1042\/bj2460503","article-title":"Preventive effect of malotilate on carbon tetrachloride-induced liver damage and collagen accumulation in the rat","volume":"246","author":"Ala-kokko","year":"1987","journal-title":"Biochem. J."},{"key":"10.1016\/j.taap.2012.04.012_bb0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/cbf.1082","article-title":"Signal transduction via the NF-\u03baB pathway: a targeted treatment modality for infection, inflammation and repair","volume":"22","author":"Ali","year":"2004","journal-title":"Cell Biochem. Funct."},{"issue":"1\u20133","key":"10.1016\/j.taap.2012.04.012_bb0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tox.2010.05.003","article-title":"Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats","volume":"274","author":"Arozal","year":"2010","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.taap.2012.04.012_bb0025","first-page":"225","article-title":"Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study","volume":"109","author":"Carpino","year":"2004","journal-title":"Ital. J. Anat. Embryol."},{"issue":"5","key":"10.1016\/j.taap.2012.04.012_bb0030","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1536\/ihj.49.605","article-title":"Comparison of losartan and carvedilol on attenuating inflammatory and oxidative response and preserving energy transcription factors and left ventricular function in dilated cardiomyopathy rats","volume":"49","author":"Chua","year":"2008","journal-title":"Int. Heart J."},{"issue":"4","key":"10.1016\/j.taap.2012.04.012_bb0035","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/HJH.0b013e3280127948","article-title":"Antioxidant activity of carvedilol in cardiovascular disease","volume":"25","author":"Dandona","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.taap.2012.04.012_bb0040","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.phrs.2006.01.007","article-title":"Evidences for prevention of nitroglycerin tolerance by carvedilol","volume":"53","author":"El-Demerdash","year":"2006","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2012.04.012_bb0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.taap.2012.04.012_bb0050","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199306243282508","article-title":"The cellular basis of hepatic fibrosis: mechanisms and treatment strategies","volume":"328","author":"Friedman","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.taap.2012.04.012_bb0055","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.taap.2012.04.012_bb0060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/17474124.2.6.803","article-title":"Advances in anti-fibrotic therapy","volume":"2","author":"Ghiassi-Nejad","year":"2008","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2012.04.012_bb0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/10408449509089886","article-title":"Oxygen and xenobiotic reductase activities of cytochrome P450","volume":"25","author":"Goeptar","year":"1995","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2012.04.012_bb0070","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1016\/S0021-9258(19)42083-8","article-title":"Glutathione S-transferases, the first enzymatic step in mercapturic acid formation","volume":"249","author":"Habig","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2012.04.012_bb0075","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1038\/sj.onc.1209943","article-title":"NF-\u03baB and the immune response","volume":"25","author":"Hayden","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2012.04.012_bb0080","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3748\/wjg.v11.i8.1141","article-title":"Alterations of mast cells and TGFb1 on the silymarin treatment for CCl4-induced hepatic fibrosis","volume":"11","author":"Jeong","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.taap.2012.04.012_bb0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1258\/0023677021912433","article-title":"Serum \u03b12-macroglobulin and cytokine measurements in an acute inflammation model in rats","volume":"36","author":"Jinbo","year":"2002","journal-title":"Lab. Anim."},{"key":"10.1016\/j.taap.2012.04.012_bb0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-2006-958032","article-title":"Effect of a lignan-enriched Fructus schisandrae extract on hepatic glutathione status in rats: protection against carbon tetrachloride toxicity","volume":"61","author":"Ko","year":"1995","journal-title":"Planta Med."},{"issue":"4","key":"10.1016\/j.taap.2012.04.012_bb0095","first-page":"325","article-title":"Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding","volume":"97","author":"Laleman","year":"2006","journal-title":"Minerva Med."},{"issue":"1","key":"10.1016\/j.taap.2012.04.012_bb0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11239-009-0318-2","article-title":"The inhibition in tumor necrosis factor-alpha-induced attenuation in endothelial thrombomodulin expression by carvedilol is mediated by nuclear factor-kappaB and reactive oxygen species","volume":"29","author":"Lin","year":"2010","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.taap.2012.04.012_bb0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.taap.2011.10.016","article-title":"Insights antifibrotic mechanisms of methyl palmitate: impact on nuclear factor kappa B and proinflammatory cytokines","volume":"258","author":"Mantawy","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2012.04.012_bb0110","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.HYP.34.6.1197","article-title":"Carvedilol and lacidipine prevent carvedilol hypertrophy and endothelin-1 gene overexpression after aortic banding","volume":"34","author":"Massart","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.taap.2012.04.012_bb0115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1742-7843.2005.pto_06.x","article-title":"Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicines and trimethylcolchicinic acid","volume":"96","author":"Muriel","year":"2005","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.taap.2012.04.012_bb0120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1536\/ihj.47.607","article-title":"Carvedilol prevents myocardial fibrosis in hamsters","volume":"47","author":"Nanjo","year":"2006","journal-title":"Int. Heart J."},{"key":"10.1016\/j.taap.2012.04.012_bb0125","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ptr.1685","article-title":"Effect of pumpkin seed (Cucurbita pepo) protein isolate on the activity levels of certain plasma enzymes in CCL4-induced liver injury in low-protein fed rats","volume":"19","author":"Nkosi","year":"2005","journal-title":"Phytother. Res."},{"key":"10.1016\/j.taap.2012.04.012_bb0130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2012.04.012_bb0135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00418-005-0785-2","article-title":"Immunohistochemical distribution of activated nuclear factor kappaB and peroxisome proliferator-activated receptors in carbon tetrachloride-induced chronic liver injury in rats","volume":"123","author":"Orfila","year":"2005","journal-title":"Histochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.taap.2012.04.012_bb0140","first-page":"1075","article-title":"Liver fibrosis: a dynamic and potentially reversible process","volume":"25","author":"Povero","year":"2010","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.taap.2012.04.012_bb0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ajcp\/28.1.56","article-title":"A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases","volume":"28","author":"Reitman","year":"1957","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.taap.2012.04.012_bb0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1179\/135100005X38879","article-title":"Cytoprotective effect of carvedilol against oxygen free radical generation in rat liver","volume":"10","author":"Ronsein","year":"2005","journal-title":"Redox Rep."},{"key":"10.1016\/j.taap.2012.04.012_bb0155","doi-asserted-by":"crossref","first-page":"G631","DOI":"10.1152\/ajpgi.00185.2007","article-title":"Selective inactivation of NF-\u03baB in the liver using NF-\u03baB decoy suppresses CCl4-induced liver injury and fibrosis","volume":"293","author":"Son","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.taap.2012.04.012_bb0160","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00534-002-0824-5","article-title":"Catalase, superoxide dismutase, and glutathione peroxidase activities in various rat tissues after carbon tetrachloride intoxication","volume":"10","author":"Szymonik-Lesiuk","year":"2003","journal-title":"J. Hepatobiliary Pancreat. Surg."},{"issue":"1","key":"10.1016\/j.taap.2012.04.012_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11894-009-0080-9","article-title":"Antifibrotic therapies: will we ever get there?","volume":"12","author":"Thompson","year":"2010","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"8","key":"10.1016\/j.taap.2012.04.012_bb0170","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/MEG.0b013e3283367a99","article-title":"The management of portal hypertension","volume":"22","author":"Tripathi","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.taap.2012.04.012_bb0175","first-page":"BR6","article-title":"Protective effects of carvedilol on systemic vascular damage induced by angiotensin II: organ-specific effects independent of antihypertensive effects","volume":"16","author":"Vialati Mdo","year":"2010","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.taap.2012.04.012_bb0180","first-page":"231","article-title":"Bilirubin direct\/total","volume":"15","author":"Walter","year":"1970","journal-title":"Microchem. J."},{"issue":"1","key":"10.1016\/j.taap.2012.04.012_bb0185","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0735-1097(00)00671-9","article-title":"Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction","volume":"36","author":"Wei","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.taap.2012.04.012_bb0190","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0003-9861(61)90291-0","article-title":"The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid","volume":"93","author":"Woessner","year":"1961","journal-title":"Arch. Biochem. Biophys."},{"issue":"12","key":"10.1016\/j.taap.2012.04.012_bb0195","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3109\/00365529609036901","article-title":"Animal models of liver fibrosis","volume":"31","author":"Wu","year":"1996","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.taap.2012.04.012_bb0200","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0008-6363(03)00459-0","article-title":"Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity","volume":"59","author":"Yang","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.taap.2012.04.012_bb0205","first-page":"G622","article-title":"Effect of central corticotropin-releasing factor on carbon tetrachloride-induced acute liver injury in rats","volume":"276","author":"Yokohama","year":"1999","journal-title":"Am. J. Physiol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12001482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12001482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:40:59Z","timestamp":1758573659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X12001482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0041008X12001482"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2012.04.012","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New therapeutic aspect for carvedilol: Antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2012.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}